Bamlanivimab for treatment of COVID-19 in solid organ transplant recipients: Early single-center experience

Clin Transplant. 2021 Apr;35(4):e14245. doi: 10.1111/ctr.14245. Epub 2021 Feb 17.

Authors

Abhay Dhand¹, Stephen A Lobo¹, Kevin Wolfe², Nicholas Feola³, Christopher Nabors¹

Affiliations

¹ Department of Medicine, Westchester Medical Center, NY, USA.
² Department of Surgery, Westchester Medical Center, NY, USA.
³ Department of Pharmacy, Westchester Medical Center, NY, USA.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antibodies, Monoclonal, Humanized / therapeutic use*
COVID-19 Drug Treatment*
Humans
Male
Middle Aged
Organ Transplantation*
Transplant Recipients*

Substances

Antibodies, Monoclonal, Humanized
bamlanivimab